David C Hodgson

David C Hodgson, MD, MPH

Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Keywords: oncology, population-based outcomes, health services research
Dr. Hodgson conducts population-based research examining the treatment and outcome of cancer patients. Ongoing studies include:
  1. Translating epidemiologic studies of radiation-related side effects into more effective and safer treatment for patients with lymphoma.
  2. Evaluating access and effectiveness of new cancer treatments and technologies in Ontario.
Beyond Expert Opinion: Progress in the Development of Evidence-Based Screening Guidelines for Survivors of Childhood Cancer.
J Natl Cancer Inst. 2018 Feb 26;:
Hodgson DC, Henderson TO
Ovarian function after chemotherapy in young breast cancer survivors.
Curr Oncol. 2017 Dec;24(6):e494-e502
Morarji K, McArdle O, Hui K, Gingras-Hill G, Ahmed S, Greenblatt EM, Warner E, Sridhar S, Ali AMF, Azad A, Hodgson DC
Proton therapy in mediastinal Hodgkin lymphoma: moving from dosimetric prediction to clinical evidence.
Ann Oncol. 2017 Sep 01;28(9):2049-2050
Ricardi U, Dabaja B, Hodgson DC
Monte Carlo-driven predictions of neurocognitive and hearing impairments following proton and photon radiotherapy for pediatric brain-tumor patients.
J Neurooncol. 2017 Aug 19;:
Fortin D, Tsang D, Ng A, Laperriere N, Hodgson DC
Best Practice Recommendations for the Retention of Radiotherapy Records.
Clin Oncol (R Coll Radiol). 2017 Aug 12;:
Lockhart E, Bak K, Schreiner LJ, Hodgson DC, Gutierrez E, Warde P, Sharpe MB
Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: A report from the Children's Oncology Group.
Pediatr Blood Cancer. 2017 Aug 12;:
Untanu RV, Back J, Appel B, Pei Q, Chen L, Buxton A, Hodgson DC, Ehrlich PF, Constine LS, Schwartz CL, Hutchison RE
[(18) F]-FDG PET/CT in the staging and management of indolent lymphoma: A prospective multicenter PET registry study.
Cancer. 2017 Mar 13;:
Metser U, Dudebout J, Baetz T, Hodgson DC, Langer DL, MacCrostie P, Mak V, Tau N
Neurocognitive function and psychological distress in young adults (YA) with cancer.
J Clin Oncol. 2016 Jan 20;34(3_suppl):199
D'Agostino NM, Pond GR, Aubin S, Matthew A, Gupta AA, Kavan P, Crump M, Bedard PL, Schuh AC, Hodgson DC, Wahl K, Simpson R, Vuong T, Muanza T, Batist G, Bernstein LJ
Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects.
Radiat Res. 2017 Jan 24;:
Gilbert ES, Curtis RE, Hauptmann M, Kleinerman RA, Lynch CF, Stovall M, Smith SA, Weathers R, Andersson M, Dores GM, Fraumeni JF, Fossa SD, Hall P, Hodgson DC, Holowaty EJ, Joensuu H, Johannesen TB, Langmark F, Kaijser M, Pukkala E, Rajaraman P, Storm...
Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial.
Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):943-950
Charpentier AM, Friedman DL, Wolden S, Schwartz C, Gill B, Sykes J, Albert-Green A, Kelly KM, Constine LS, Hodgson DC

Pages


 
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre

Associate Professor, Department of Radiation Oncology, University of Toronto
Staff Radiation Oncologist, Princess Margaret Cancer Centre